Lidocaine/prilocaine - Plethora Solutions

Drug Profile

Lidocaine/prilocaine - Plethora Solutions

Alternative Names: Fortacin; Prilocaine Lidocaine Plethora; Prilocaine/lidocaine; PSD-502; Tempe

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Plethora Solutions
  • Class Acetanilides; Anilides; Erectile dysfunction therapies; Local anaesthetics; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Premature ejaculation
  • Discontinued Pain

Most Recent Events

  • 11 Nov 2016 Launched for Premature ejaculation in United Kingdom (Topical)
  • 15 May 2015 Lidocaine/prilocaine is still in active development for Premature ejaculation in USA and Canada
  • 14 Apr 2015 Plethora Solutions plans NDA submission for Premature ejaculation in the US in Q1 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top